A newly developed test could help doctors more accurately predict whether individuals who undergo gastric bypass surgery will experience a remission of type 2 diabetes within two years of the procedure, according to University of Utah Health scientists.
U of U Health scientists found that low ceramide levels prior to gastric bypass surgery predicted which patients would achieve remission of the diabetes